Suvoda's IRT Recognized as Leader in Everest Group's PEAK Matrix® RTSM Assessment

Suvoda IRT Named Leader in Everest Group’s PEAK Matrix® RTSM

Suvoda, a prominent player in the clinical trial technology arena, has recently been recognized for its excellence in the field. The company announced that its Interactive Response Technology (IRT), which is also referred to as Randomization and Trial Supply Management (RTSM), has been named a leader in the 2025 PEAK Matrix® assessment by the Everest Group.

This evaluation is a deep-dive analysis that assesses various technology providers based on their market impact, vision, and delivery capabilities. It involves direct client interviews that reveal insights about actual performance and user experience, adding a layer of credibility to the findings.

Market Adoption and Innovation

The recognition from the Everest Group reflects Suvoda's robust market presence, innovative approach, and technical strength in the RTSM sector. As highlighted by Nisarg Shah, Practice Director at Everest Group, Suvoda demonstrates particular expertise in managing highly complex multi-arm studies, attributing this capability to its low-code/no-code platform, Virtual Partition framework, and extensive integration network.

Suvoda’s modular architecture and flexible study configuration allow it to adapt swiftly to the most complicated study protocols, coupled with real-time inventory visibility and predictive restocking functions. The platform continues to evolve in response to study changes, facilitated by built-in customization tools supported by several patents showcasing the company’s innovative spirit.

Enhancing Clinical Trial Logistics

Suvoda IRT acts as a command center for clinical trial logistics, enabling sponsors, Contract Research Organizations (CROs), and sites to administer appropriate treatment to the right patients at the right times. This ensures an optimized trial process, increasing efficiency and potentially improving outcomes.

Jagath Wanninayake, CEO of Suvoda, expressed pride in the company’s recognition, stating, "This honor validates that Suvoda IRT provides unmatched capabilities and speed in randomization and supply management for complex clinical trials." He emphasized the company's continuous efforts to enhance the platform by integrating IRT with a broader range of products, ensuring that the most critical and urgent moments in their studies are managed effectively.

Introduction of Sofia, the AI Assistant

In a bid to further improve usability, Suvoda recently launched Sofia, an AI assistant designed to streamline the tasks of drug supply managers. This tool optimizes data retrieval, inventory monitoring, visit schedules, and data visualization, all within a conversational interface, making it easier for users to navigate the complexities of clinical trials.

Additionally, the system provides real-time analytics through predefined and ad-hoc reports, enabling teams to make informed decisions swiftly. This combination of technological innovation profoundly impacts the management and execution of clinical trials, enhancing overall operational efficiency.

Conclusion

Suvoda has set a new benchmark in the clinical trial industry, transforming the experience for sponsors, CROs, sites, and patients alike through innovative solutions that make clinical trials more intuitive. With its commitment to continual improvement and a user-centered approach, Suvoda is poised to lead in clinical trial technology for years to come.

For more in-depth insights, individuals are encouraged to access the Everest Group's report on Suvoda IRT for a comprehensive understanding of its capabilities and market positioning.

About Suvoda

Suvoda is a global company specializing in clinical trial technology, offering real-time experience platforms that empower sponsors and CROs to make confident decisions while allowing sites and patients to act with calm and control. With interconnected, actionable software solutions, alongside industry-leading services and support, Suvoda strives to facilitate pivotal studies even in the most urgent scenarios.

For more information, visit suvoda.com and follow Suvoda on LinkedIn.